FDA Approves HIV Drug Based on University of Utah Biochemist's Findings

A University of Utah doctor’s research led to a major HIV drug. He worries federal cuts will stop people from getting it.

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah biochemist whose discoveries helped make the drug happen worries government cuts will make it harder to get the drug to those who need it.

‘Monumental’ HIV shot could be coming to Canada. What we know

Health-care experts and advocates say Gilead's HIV prevention shot could be a "wonder drug," but there is concerns about accessiblity.

Wasted miracle? Concerns as revolutionary HIV drug approved

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

FDA approves HIV drug based on University of Utah biochemist's findings

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.

The decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir

On Thursday, the FDA approved lenacapavir, to be sold as Yeztugo, for the prevention of HIV in the U.S. The below essay, adapted from “Breakthrough: The Quest for Life-Changing Medicine” by William Pao, looks at lenacapavir’s decades-long journey to approval. By the mid-1990s, the AIDS epidemic had become a pandemic, with more than 3 million new HIV infections and more than 1 million AIDS-related deaths each year. A million children, most of the…

Pharmacist-Led Review Uncovers Frequent ART Errors in Hospitalized Adults With HIV

More than 80% of patients had drug-related problems, highlighting the need for inpatient antiretroviral stewardship.